Injectable Nanomedicine Market size is expected to reach US$ 1067.7 Mn by 2029, at a CAGR of 8.2% during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To Know About The Research Methodology :- Request Free Sample Report The Global Injectable Nanomedicine Market Definition The nanotechnology-based drug delivery systems have wide applications in ocular diseases. The tool of nanotechnology provides several essential advantages, including sustained drug release and specific tissue targeting. Injectable nanomedicines have made an impact on cancer, CNS disease, cardiovascular disease, and infection control.
Global Injectable Nanomedicine Market Dynamics
Nanomedicine has been extensively investigated in the application of different drug delivery systems for injectable routes of administration. Novel nanomedicines have been developed and utilized for the treatment of many diseases. In addition to the targeted delivery of therapeutics, nanomedicine can also be used to release drugs in a controlled manner. This can result in improved outcomes for patients due to a reduction in toxicity, more efficient delivery of therapeutic molecules, and a longer lifetime of drugs within the body. Improvement in the balance between nanomedicine efficacy and toxicity is the opportunity for the global injectable nanomedicine market. Many emerging economies such as Brazil, China, India, Iran, Malaysia, Mexico, Singapore and South Africa have ambitious research and development (R&D) plans for nanotechnology. Their governments need to balance short-term health needs with long-term technological investment. Nanomedicine opens a new frontier in cancer treatment BioNtec and Pfizer are spending onnanomedicineowing to growing demand to target tumor cancer. Their goal is to create more precise and effective cancer treatment with fewer side effects. A rising number of successful outcomes of nanomedicines in cancer patients and could represent a huge achievement for molecular medicine and biotechnology. Global industries are now sensing business opportunities in nanomedicine. They have started realizing the commercial worth and viability of nanotechnology-based products and their impact on the national economy. It is estimated that around 100 companies are working on the scope of nanomedicine in the area of pharma or nanobiopharma. While more than half a dozen have even commercialized nanomedicine-based products. Worldwide companies like Biocon, Lifecare Innovations, Cadila, Lupin, Cipla, Sun Pharma, Ranbaxy, etc., have already commercialized nanotechnology-based products & have also extended their products to the medical research centers of North America. Despite the recent approval of several nanomedicinal anticancer drugs, such as Onivyde and Vyxeos, the success rate of clinical translation remains relatively low. The Striking imbalance between the ever-increasing number of preclinical studies reporting the development of more complex nanomedicines and the relatively small number of nanomedicine products approved for clinical use, on the other hand, has become a challenge for the global market.Segment Analysis
Polymeric nanoparticles (PNP) are the major drug type segment for the injectable nanomedicine market. The demand for polymeric nanoparticles has expressively increased in the past few years & is estimated to rise further over the forecast period. Cancer, neurodegenerative disorders, and cardiovascular diseases are fields impacted by NP technologies that push scientific boundaries to the leading edge of transformative advances for nanomedicine market. When it comes to applications of PNPs in oral drug delivery, most PNPs have US Food and Drug Administration (FDA) and approved as safe for human use. The Asia Pacific government has been funding research and development (R&D) in the area of nanomedicine with the intention to address specific societal needs and to be a forerunner in this area. Newly diagnosed various cancers led to an opportunity for Injectable Nanomedicine Research and Drug Development. Innovation center of NanoMedicine researchers recently in 2021 develop ultra-small nanomedicines to target intractable cancers. This and many more ongoing cancer nanomedicine research activities in European countries resulting in the launches of nanomedicines for cancer treatment.The conduct of an integrated, milestone-driven and product-oriented program by the National Cancer Institute on cancer nanotechnology aimed at eliminating the burden of cancer. Rapidly ongoing new technology discoveries and their transformation into cancer-relevant applications in clinical practice is a great opportunity for the global market in the next five years.Regional Analysis
North America is expected to dominate the global injectable nanomedicine market during the forecast period. As a part of a new pathway to discovery project, the US National Institute of Health (NIH) has granted US$ 42 million over five years to establish four nanomedicine development centers. The US National Science Foundation (NSF) is granting US $ 20 million over five years to a Nanoscale Informal Science Education. These kinds of government funding support to the R & D team resulting in the large number of injectable nanomedicines coming up in the treatment and diagnostic centers.Global Injectable Nanomedicine Market Report Scope
The objective of the report is to present a comprehensive analysis of the global injectable nanomedicine market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global injectable nanomedicine market dynamics, structure by analyzing the market segments and project the global injectable nanomedicine market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global injectable nanomedicine market make the report investor’s guide.Global Injectable Nanomedicine Scope: Inquiry before Buying
Global Injectable Nanomedicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 614.9 Mn. Forecast Period 2023 to 2029 CAGR: 8.2% Market Size in 2029: US $ 1067.7 Mn. Segments Covered: by Drug Type Liposomes Micelles Nanocrystals Polymeric Nanoparticles Metallic Nanoparticles Mesoporous Silica Nanoparticles Others by Application Cancer Central Nervous System Disease Cardiovascular Disease Infection Control Inflammatory Disease Others by End Users Hospitals Ambulatory surgical center Clinics Specialized drugs R&D institutes Managed care organizations Global Injectable Nanomedicine Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Injectable Nanomedicine Market Key Players
1. Merck & Co. Inc. 2. Lupin 3. Pacira Pharmaceuticals Inc. 4. Celgene Pharmaceutical Co. Ltd. 5. Amgen, Inc. 6. Janssen Biotech Inc. 7. Johnson & Johnson Services Inc. 8. Pfizer Inc. 9. Hoffmann-La Roche Ltd. 10.TevaPharmaceutical Industries Ltd. 11.Bausch & Lomb Incorporated 12.Others Frequently Asked Questions: 1. Which region has the largest share in Global Injectable Nanomedicine Market Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Injectable Nanomedicine Market Market? Ans: The Global Injectable Nanomedicine Market Market is growing at a CAGR of 8.2% during forecasting period 2023-2029. 3. What is scope of the Global Injectable Nanomedicine Market Market report? Ans: Global Injectable Nanomedicine Market Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Injectable Nanomedicine Market Market? Ans: The important key players in the Global Injectable Nanomedicine Market Market are –Merck & Co. Inc.,Lupin, Pacira Pharmaceuticals Inc.,Celgene Pharmaceutical Co. Ltd.,Amgen,Inc.,Janssen Biotech Inc.,Johnson & Johnson Services Inc.,Pfizer Inc. 5. What is the study period of this Market? Ans: The Global Injectable Nanomedicine Market Market is studied from 2022 to 2029.
Global Injectable Nanomedicine Market
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Injectable Nanomedicine Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Injectable Nanomedicine Market 3.4. Geographical Snapshot of the Injectable Nanomedicine Market, By Manufacturer share 4. Global Injectable Nanomedicine Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Injectable Nanomedicine Market 5. Supply Side and Demand Side Indicators 6. Global Injectable Nanomedicine Market Analysis and Forecast, 2019-2026 6.1. Global Injectable Nanomedicine Market Size & Y-o-Y Growth Analysis. 7. Global Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 7.1.1. Liposomes 7.1.2. Micelles 7.1.3. Nanocrystals 7.1.4. Polymeric Nanoparticles 7.1.5. Metallic Nanoparticles 7.1.6. Mesoporous Silica Nanoparticles 7.1.7. Others 7.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 7.2.1. Cancer 7.2.2. Central Nervous System Disease 7.2.3. Cardiovascular Disease 7.2.4. Infection Control 7.2.5. Inflammatory Disease 7.2.6. Others 7.3. Market Size (Value) Estimates & ForecastBy End users, 2019-2026 7.3.1. Hospitals 7.3.2. Ambulatory surgical center 7.3.3. Clinics 7.3.4. Specialized drugs R&D institutes 7.3.5. Managed care organizations 8. Global Injectable Nanomedicine Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 9.1.1. Liposomes 9.1.2. Micelles 9.1.3. Nanocrystals 9.1.4. Polymeric Nanoparticles 9.1.5. Metallic Nanoparticles 9.1.6. Mesoporous Silica Nanoparticles 9.1.7. Others 9.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 9.2.1. Cancer 9.2.2. Central Nervous System Disease 9.2.3. Cardiovascular Disease 9.2.4. Infection Control 9.2.5. Inflammatory Disease 9.2.6. Others 9.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 9.3.1. Hospitals 9.3.2. Ambulatory surgical center 9.3.3. Clinics 9.3.4. Specialized drugs R&D institutes 9.3.5. Managed care organizations 10. North America Injectable Nanomedicine Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 11.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 11.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 12. Canada Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 12.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 12.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 13. Mexico Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 13.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 13.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 14. Europe Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 14.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 14.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 15. Europe Injectable Nanomedicine Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 16.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 16.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 17. France Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 17.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 17.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 18. Germany Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 18.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 18.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 19. Italy Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 19.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 19.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 20. Spain Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 20.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 20.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 21. Sweden Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 21.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 21.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 22. CIS CountriesInjectable Nanomedicine Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 22.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 22.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 23. Rest of Europe Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 23.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 23.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 24. Asia Pacific Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 24.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 24.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 25. Asia Pacific Injectable Nanomedicine Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & ForecastBy Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 26.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 26.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 27. India Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 27.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 27.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 28. Japan Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 28.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 28.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 29. South Korea Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 29.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 29.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 30. Australia Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 30.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 30.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 31. ASEAN Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 31.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 31.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 32. Rest of Asia Pacific Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 32.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 32.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 33. Middle East Africa Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 33.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 33.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 34. Middle East Africa Injectable Nanomedicine Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 35.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 35.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 36. GCC Countries Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 36.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 36.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 37. Egypt Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 37.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 37.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 38. Nigeria Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 38.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 38.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 39. Rest of ME&A Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 39.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 39.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 40. South AmericaInjectable Nanomedicine Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 40.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 40.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 41. South America Injectable Nanomedicine Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 42.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 42.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 43. Argentina Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 43.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 43.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 44. Rest of South America Injectable Nanomedicine Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & ForecastBy Drug Type, 2019-2026 44.2. Market Size (Value) Estimates & ForecastBy Application, 2019-2026 44.3. Market Size (Value) Estimates & ForecastBy End Users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Injectable Nanomedicine Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Merck & Co. Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Lupin 45.3.3. Pacira Pharmaceuticals Inc. 45.3.4. Celgene Pharmaceutical Co. Ltd. 45.3.5. Amgen, Inc. 45.3.6. Janssen Biotech Inc. 45.3.7. Johnson & Johnson Services Inc. 45.3.8. Pfizer Inc. 45.3.9. Hoffmann-La Roche Ltd. 45.3.10. Teva Pharmaceutical Industries Ltd. 45.3.11. Bausch & Lomb Incorporated 45.3.12. Others 46. Primary Key Insights